| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer | Chief Scientific Officer
1 company
Kirson Eilon D. is a Chief Science Officer at NovoCure Ltd. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2017 | NVCR Novocure Ltd | Chief Science Officer | Sell | 20,956 | $15.03 | $315,053.39 | -3.2% |